Data Insights

Docetaxel albumin bound by CSPC Pharmaceutical Group for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval

Docetaxel albumin bound is under clinical development by CSPC Pharmaceutical Group and currently in Phase II for Recurrent Head And...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel Albumin Bound in Recurrent Head And Neck Squamous Cell Carcinoma

Data Insights

Docetaxel albumin bound by CSPC Pharmaceutical Group for Oral Cavity (Mouth) Cancer: Likelihood of Approval

Docetaxel albumin bound is under clinical development by CSPC Pharmaceutical Group and currently in Phase II for Oral Cavity (Mouth)...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel Albumin Bound in Oral Cavity (Mouth) Cancer

Data Insights

Docetaxel albumin bound by CSPC Pharmaceutical Group for Oropharyngeal Cancer: Likelihood of Approval

Docetaxel albumin bound is under clinical development by CSPC Pharmaceutical Group and currently in Phase II for Oropharyngeal Cancer. According...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel Albumin Bound in Oropharyngeal Cancer

Data Insights

Docetaxel albumin bound by CSPC Pharmaceutical Group for Laryngeal Cancer: Likelihood of Approval

Docetaxel albumin bound is under clinical development by CSPC Pharmaceutical Group and currently in Phase II for Laryngeal Cancer. According...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel Albumin Bound in Laryngeal Cancer

Data Insights

Docetaxel albumin bound by CSPC Pharmaceutical Group for Hypopharyngeal Cancer: Likelihood of Approval

Docetaxel albumin bound is under clinical development by CSPC Pharmaceutical Group and currently in Phase II for Hypopharyngeal Cancer. According...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel Albumin Bound in Hypopharyngeal Cancer

Data Insights

Docetaxel albumin bound by CSPC Pharmaceutical Group for Metastatic Prostate Cancer: Likelihood of Approval

Docetaxel albumin bound is under clinical development by CSPC Pharmaceutical Group and currently in Phase I for Metastatic Prostate Cancer....

Data Insights

Docetaxel albumin bound by CSPC Pharmaceutical Group for Solid Tumor: Likelihood of Approval

Docetaxel albumin bound is under clinical development by CSPC Pharmaceutical Group and currently in Phase I for Solid Tumor. According...

Data Insights

Docetaxel albumin bound by CSPC Pharmaceutical Group for Gastric Cancer: Likelihood of Approval

Docetaxel albumin bound is under clinical development by CSPC Pharmaceutical Group and currently in Phase I for Gastric Cancer. According...

Data Insights

Docetaxel albumin bound by CSPC Pharmaceutical Group for Prostate Cancer: Likelihood of Approval

Docetaxel albumin bound is under clinical development by CSPC Pharmaceutical Group and currently in Phase I for Prostate Cancer. According...